PLx Pharma Inc expected to post a loss of 46 cents a share - Earnings Preview

PLx Pharma Winddown

10/11/2021 14:24

* PLx Pharma Inc  PLXP.OQ   PLXP.O  is expected to show a rise
in quarterly revenue when it reports  results on November 12. 
* The Sparta, New Jersey-based company is expected to report
revenue of $4.1 million, according to the mean estimate from 4
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for PLx Pharma Inc is for a
loss of 46 cents per share. For the same quarter last year, the
company reported a loss of 40 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for PLx Pharma Inc
is $22​, about 39.6% above​ its last closing price
of $13.28. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.23       -0.22      -0.79     Missed  -264.6
 Mar. 31 2021  -0.21       -0.21      -0.73     Missed  -242.2
 Dec. 31 2020  -0.29       -0.29      -0.87     Missed  -200​
 Sep. 30 2020  -0.42       -0.42      -0.40     Beat    5.9
 ​​Jun.        -0.41       -0.41      -0.66     Missed  -59
 30 2020                                                
 Mar. 31 2020  -0.40       -0.39      0.08      Beat    120.3​
 Dec. 31 2019              -0.48      -0.25     Beat    47.9
 Sep. 30 2019  -0.50       -0.49      0.09      Beat    118.2
 This summary was machine generated November 10 at 14:24 GMT. 
All figures in US dollars  unless otherwise stated